🇺🇸 FDA
Patent

US 9522871

Preparation of (R,R)-fenoterol and (R,R)-or (R,S)-fenoterol analogues and their use in treating congestive heart failure

granted A61PA61P11/00A61P11/06

Quick answer

US patent 9522871 (Preparation of (R,R)-fenoterol and (R,R)-or (R,S)-fenoterol analogues and their use in treating congestive heart failure) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61P, A61P11/00, A61P11/06, A61P9/00, A61P9/04